Tyk2 Targeting in Immune-Mediated Inflammatory Diseases
The Janus kinase (Jak)/signal transducer and activating protein (STAT) pathways mediate the intracellular signaling of cytokines in a wide spectrum of cellular processes. They participate in physiologic and inflammatory cascades and have become a major focus of research, yielding novel therapies for...
Main Authors: | Lluís Rusiñol, Luis Puig |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/4/3391 |
Similar Items
-
Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis
by: Lluís Rusiñol, et al.
Published: (2024-01-01) -
TYK2 in Immune Responses and Treatment of Psoriasis
by: Shang L, et al.
Published: (2022-09-01) -
Spotlight on the treatment armamentarium of concomitant psoriasis and inflammatory bowel disease: a systematic review
by: Claudio Conforti, et al.
Published: (2022-04-01) -
Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies
by: Elisabetta Bianchi, et al.
Published: (2021-09-01) -
Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study
by: Maximilian Kutschera, et al.
Published: (2022-09-01)